Though it certainly doesn’t feel like it, Oracle (NASDAQ:ORCL) shares finished 2025 with respectable, market-beating gains ...

David Ellison may already be in a stronger position than his father was in 2003. The Paramount bid is all-cash, fully financed and carries a clear headline premium, even if WBD disputes elements of ...

Hospitals and health systems are entering a period of rapid acceleration in AI. Clinical leaders are reporting tangible gains, from automated note-taking to clearer visibility into patient histories, ...

Oracle's 2052 bonds are offering a rare 7% yield. Read about the risks and if they're right for income-focused investors.

IT stocks generally offer moderate but consistent dividends. However, investors must remember that dividends are only one ...

There is no doubt what took centre stage in the theatre of business applications in 25: agentic AI, surpassing pre-2022 AI, ...

Quick Read Oracle (ORCL) stock dropped over 40% from its September peak of $877B valuation. Oracle’s $300B OpenAI contract ...

Rural hospitals are overcoming fears of artificial intelligence and adopting tools that integrate with electronic health ...

Buffett has long advocated investing in reliable, low-risk index funds, such as the S&P 500, for most investors. If you’re ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

From early academic curiosity to enterprise-scale innovation, Rajesh G.’s journey reflects how strong foundations, continuous ...